Abstract
Highlights & Happenings provides brief, informative updates on important events and newsworthy items related to biosecurity and bioterrorism. It covers a broad array of topics, including, for example, new advances in bioresearch that could affect national security, the status of biopreparedness and response, emerging legal issues affecting vaccine and other countermeasure development and delivery, and noteworthy meetings, conferences, and reports. Readers may submit items of interest to the column's editor, Crystal Franco, through the Journal's editorial office at
TFAH 2011 Ready or Not Report: Preparedness Suffering from Funding Cuts
Now in its ninth year, the report provides independent analysis of progress and vulnerabilities in public health preparedness. Previous reports had shown that, although major gaps remained, significant improvements were made in the nation's ability to prevent, diagnose, and respond to health emergencies after 2001. However, since the economic crisis hit, cuts to budgets and staff at the local, state, and federal levels have begun to eat away at this progress. 1
“We're seeing a decade's worth of progress eroding in front of our eyes,” said Jeff Levi, Executive Director of TFAH. “Preparedness had been on an upward trajectory, but now some of the most elementary capabilities—including the ability to identify and contain outbreaks, provide vaccines and medications during emergencies, and treat people during mass traumas—are experiencing cuts in every state across the country.” Mel Kohn, State Health Officer and Public Health Director of the Oregon Health Authority, stated, “We have reached the point where our ability to do this work will be seriously compromised, with life and death consequences.” 2
Key findings from the report:
• Fifty-one cities, located in 40 states, are at risk for elimination of Cities Readiness Initiative funds, which support the ability to rapidly distribute and administer vaccinations and medications during emergencies. • All 10 state labs with “Level 1” chemical threat testing status are at risk of losing top-level capabilities, which could leave the U.S. Centers for Disease Control and Prevention (CDC) with the only public health lab in the country with full chemical testing capabilities. • Twenty-four states are at risk of losing expert epidemiology support, which has supplemented state and local gaps in the past. • Academic preparedness research and training centers are at risk due to budget cuts. • Potential cuts to the National Center for Environmental Health (NCEH) mean the ability for CDC to mount a comprehensive response to nuclear detonation, radiological attacks, chemical attacks, and natural disasters is at risk. • Forty states and Washington, DC, cut their state public health budgets; 29 states cut their budgets for the second year in a row, 15 for 3 years in a row. • Forty-one states had cuts in state and local preparedness support through the Public Health Emergency and Preparedness (PHEP) grants from FY2010 to FY2011. • All 50 states and Washington, DC, had cuts in the Hospital Preparedness Program (HPP) from FY2010 to FY2011.
1
The report also includes a series of recommendations to improve America's preparedness:
• Assure dedicated funding and strengthen the public health preparedness core capabilities; • Improve biosurveillance to rapidly detect and track outbreaks or attacks; • Improve research, development, and manufacturing of vaccines and medications; • Enhance the ability to provide care for a mass influx of patients during emergencies; • Provide better support to help communities cope with and recover from disasters; and • Coordinate food safety with other preparedness efforts through the strategic implementation of the FDA Food Safety Modernization Act of 2011.
2
Tara Kirk Sell
Outcomes of the 7th Review Conference on the Biological and Toxin Weapons Convention
On December 5, 2011, the 165 states parties gathered in Geneva for the 7th BWC review conference. Leading up to the conference, the White House and the U.S. Department of State had taken steps to establish U.S. priorities and build consensus among other states parties. Notably, at a 2009 intersessional meeting, Under Secretary of State for Arms Control and International Security Affairs Ellen Tauscher announced preliminary U.S. priorities along with the President's National Strategy for Countering Biological Threats.
2
Building off these previous efforts, Secretary of State Hillary Clinton addressed the conference on December 7 to announce a 3-fold focus moving forward:
3
1. Strengthen implementation of the convention. 2. Create a regular and systematic review of scientific and technological developments in the life sciences relevant to the convention. 3. Improve disease surveillance, disease outbreak response and management, and biosafety.
Based on the final declaration and recommendations and decisions, the U.S. appears to have been largely successful in integrating their priorities into the BWC's implementation strategy for the next 5 years. 4 The U.S. hopes to champion confidence-building measure (CBM) efforts as an alternative to binding verification protocols. To that end, Secretary Clinton announced a new Bio-Transparency and Openness Initiative, which will feature a U.S.-hosted forum to discuss biological threats as well as bioresearch programs, and tours of U.S. biodefense facilities. The conference also agreed to establish an electronic database system to facilitate the exchange of CBMs among states parties.
Despite this incremental progress, several challenges and conflicts arose during discussions. Many states parties voiced financial concerns as the ongoing global economic downturn threatens many countries' ability to budget resources for BWC goals. Russia and the European Union continue to press for legally binding verification protocols, while the U.S. continues to contend that meaningful verification cannot be achieved through static verification protocols given the dual-use nature of most life science technology. Moreover, U.S. efforts to allow for a more “nimble” implementation process by permitting decision making at annual intersessional meetings were met with some resistance and did not proceed. 5
Article X of the BWC, which stipulates the promotion of peaceful uses of biological science and technology, continues to draw focus from states parties moving forward. In an effort to increase engagement and participation in the BWC, the capable parties agreed to provide technical assistance and support to other countries for the development of beneficent life science products such as vaccines and drugs to treat infectious diseases. Furthermore, implementation efforts will emphasize efforts to detect and respond to infectious disease events. 4 The BWC appears to increasingly parallel the goals of the International Health Regulations and the efforts of the World Health Organization. In doing so, the BWC will likely continue to be relevant to all states parties as it promotes constructive applications of the biosciences and global health security.
Samuel Wollner
HHS Releases Global Health Strategy to Advance International Health Efforts
As introduction to the strategy document, Secretary of HHS Kathleen Sebelius emphasized the importance of “global public health in realizing not only our own diplomatic and security goals, but also the goals of other nations…to improve the health and well-being of people throughout the world to help make a safer and more secure world community.” Secretary Sebelius asserted that the efforts of HHS and the U.S. government to improve global health will also “afford the [U.S. the] opportunity to prevent and detect coming health crises domestically and abroad, a greater ability for us to learn from other nations' success, and more sustainable health systems that effectively protect and secure health.” 1
According to the strategy document, HHS approaches global health activities through several core operating principles, including:
• emphasizing prevention; • using evidence-based knowledge to inform decisions; • responding to local needs and building local capacities; • partnership and coordination; • improving the equity of health; and • ensuring a lasting and measurable impact.
2
The strategy includes 3 main goals that are supported by 10 critical objectives, all of which are intended to guide agencies in HHS to advance global health activities. The 3 goals outlined in the strategy aim to improve the health of all nations:
1
1. Protect and promote the health and well-being of Americans through global health action. 2. Provide leadership and technical expertise in science, policy, programs, and practice to improve global health. 3. Work in conjunction with interagency partners to advance U.S. interests in international diplomacy, development, and security through global health action.
In support of the 3 global health goals, HHS further outlined 10 critical objectives and priority actions to guide and advance agency work in global health:
3
1. To enhance global surveillance to detect, control, and prevent diseases and health concerns; 2. To prevent infectious diseases and other threats from crossing borders; 3. To prepare for and respond to global outbreaks and public health emergencies; 4. To increase the safety and reliability of global manufacturing and supply chains for food, feed, and medical products; 5. To strengthen and implement international science-based global health and safety standards; 6. To utilize biomedical and public health research and innovation for new interventions that improve health and well-being; 7. To address the changing global patterns of death, illness, and disability; 8. To identify and exchange best practices to improve health strategies and health systems; 9. To support the President's Global Health Initiative to achieve major improvements in health outcomes for women, children, and families; and 10. To advance health diplomacy through scientific and technical expertise.
HHS's Global Health Strategy recognizes that to advance global health, a coordinated U.S. government approach is needed, in addition to collaboration and cooperation with multilateral organizations, other national governments, and civil society and nongovernmental organizations. Key partners in the U.S. government include the U.S. Agency for International Development, the Department of State, the Department of Defense, and other departments engaged in global efforts to improve nutrition, environmental health, development, health security, and food security. HHS also continues to work with more than 190 national ministries of health and scientific and regulatory agencies and many health-related multilateral organizations, such as the World Health Organization, the United Nations Children's Fund, the World Bank, and the Global Fund to Fight AIDS, Tuberculosis, and Malaria. 1
Nidhi Bouri
